Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRS3 | P32247 | 10/20 | 0.77 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29406766 | 1.00 | BRS3 (0.77) | BRS3GAAPTGS1PTGS2ADORA3 | |
| SCHEMBL29566071 | 1.00 | BRS3 (0.77) | BRS3GAAPTGS1PTGS2ADORA3 | |
| SCHEMBL29565771 | 1.00 | BRS3 (0.77) | BRS3GAAPTGS1PTGS2ADORA3 | |
| SCHEMBL29423343 | 1.00 | BRS3 (0.77) | BRS3GAAPTGS1PTGS2ADORA3 | |
| SCHEMBL9367348 | 1.00 | BRS3 (0.77) | BRS3GAAPTGS1PTGS2ADORA3 | |
| SCHEMBL29478433 | 1.00 | BRS3 (0.77) | BRS3GAAPTGS1PTGS2ADORA3 | |
| SCHEMBL9367335 | 1.00 | BRS3 (0.77) | BRS3GAAPTGS1PTGS2ADORA3 | |
| SCHEMBL9366479 | 1.00 | BRS3 (0.77) | BRS3GAAPTGS1PTGS2ADORA3 | |
| SCHEMBL9370827 | 1.00 | BRS3 (0.77) | BRS3GAAPTGS1PTGS2ADORA3 | |
| SCHEMBL9367469 | 1.00 | BRS3 (0.77) | BRS3GAAPTGS1PTGS2ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260118820-A1 | LIGHT GUIDE PLATE FOR IMAGE DISPLAY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-04-30 | — | — | US | disclosed |
| US-12604600-B2 | Organic electroluminescent element and novel iridium complex | UDC Ireland (IE) | 2026-04-14 | — | — | US | disclosed |
| US-20260073030-A1 | METHODS, SYSTEMS, APPARATUSES, AND DEVICES FOR FACILITATING SELF-OPTIMIZABLE BIOMETRIC IDENTITY VERIFICATION OF USERS | LIU JIAN (US) | 2026-03-12 | — | — | US | disclosed |
| EP-3413922-B1 | IMPROVED SULFAMIDE LINKERS FOR USE IN BIOCONJUGATES | SYNAFFIX BV (NL) | 2025-12-10 | — | — | EP | disclosed |
| US-12487560-B2 | Light guide plate for image display | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-12-02 | — | — | US | disclosed |
| US-12404264-B2 | Organic electric light emitting element, material for said element, and light emitting device, display device, and illumination device employing said element | UDC IRELAND LIMITED (IE) | 2025-09-02 | — | — | US | disclosed |
| EP-3926018-B1 | COATING COMPOSITION | KANSAI PAINT CO LTD (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-20250072286-A1 | POLYCYCLIC COMPOUND AND ORGANOELECTRO LUMINESCENT DEVICE USING THE SAME | SFC CO., LTD. (KR) | 2025-02-27 | — | — | US | disclosed |
| WO-2025028411-A1 | PLANT MILK COMPOSITION | 株式会社ADEKA | 2025-02-06 | — | — | WO | disclosed |
| US-20250044737-A1 | LIGHT GUIDE PLATE FOR IMAGE DISPLAY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-02-06 | — | — | US | disclosed |
| US-11631825-B2 | Organic electroluminescent element and novel iridium complex | UDC IRELAND LIMITED (IE) | 2023-04-18 | — | — | US | disclosed |
| US-11563178-B2 | Organic electroluminescent element, compound for use in the element, and light emitting device, display device, and illumination device using the element | UDC IRELAND LIMITED (IE) | 2023-01-24 | — | — | US | disclosed |
| EP-3211057-B2 | ORGANIC ELECTROLUMINESCENT DEVICES AND METAL COMPLEX COMPOUNDS | UDC IRELAND LTD (IE) | 2022-11-02 | — | — | EP | disclosed |
| US-20220344601-A1 | Organic Electroluminescent Devices and Metal Complex Compounds | UDC IRELAND LTD (IE) | 2022-10-27 | — | — | US | disclosed |
| US-11393989-B2 | Organic electroluminescent devices and metal complex compounds | UDC IRELAND LIMITED (IE) | 2022-07-19 | — | — | US | disclosed |
| CN-113423791-B | Coating composition | 关西涂料株式会社 | 2022-06-21 | — | — | CN | disclosed |
| CN-111040779-B | Liquid crystal vertical self-alignment additive and preparation method and application thereof | 北京八亿时空液晶科技股份有限公司 | 2022-06-10 | — | — | CN | disclosed |
| US-20220162458-A1 | PAINT COMPOSITION | KANSAI PAINT CO., LTD. (JP) | 2022-05-26 | — | — | US | disclosed |
| US-11292936-B2 | Coating composition | KANSAI PAINT CO., LTD. (JP) | 2022-04-05 | — | — | US | disclosed |
| US-20220077413-A1 | Organoelectroluminescent Element, and Light Emission Device, Display Device, and Illumination Device in which Said Organoelectroluminescent Element is Used | UDC IRELAND LTD (IE) | 2022-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250072286-A1 | POLYCYCLIC COMPOUND AND ORGANOELECTRO LUMINESCENT DEVICE USING THE SAME | PPOX, LEF1, PKD1 | BRS3 3875/4885GAA 2878/4885PTGS1 1732/4885 |
| US-20220344601-A1 | Organic Electroluminescent Devices and Metal Complex Compounds | EPCAM, TPR, L1CAM | BRS3 4421/4885GAA 2170/4885PTGS1 4257/4885 |
| US-20260118820-A1 | LIGHT GUIDE PLATE FOR IMAGE DISPLAY | SERPINB10, VSIG8, SEM1 | BRS3 1496/4885GAA 3300/4885PTGS1 2929/4885 |
| US-12404264-B2 | Organic electric light emitting element, material for said element, and light emitting device, display device, and illumination device employing said element | NR0B1, NR2E1, NR1D1 | BRS3 4225/4885GAA 4473/4885PTGS1 1402/4885 |
| US-11563178-B2 | Organic electroluminescent element, compound for use in the element, and light emitting device, display device, and illumination device using the element | L1CAM, RER1, H1-0 | BRS3 3426/4885GAA 2166/4885PTGS1 1606/4885 |
| US-12604600-B2 | Organic electroluminescent element and novel iridium complex | CTCF, GLRB, GLRA1 | BRS3 2710/4885GAA 3703/4885PTGS1 3691/4885 |
| US-11631825-B2 | Organic electroluminescent element and novel iridium complex | CTCF, AP1M1, CLIC4 | BRS3 3951/4885GAA 3095/4885PTGS1 4216/4885 |
| US-20260073030-A1 | METHODS, SYSTEMS, APPARATUSES, AND DEVICES FOR FACILITATING SELF-OPTIMIZABLE BIOMETRIC IDENTITY VERIFICATION OF USERS | BMP2, BMP1, BMP6 | BRS3 1862/4885GAA 2960/4885PTGS1 2739/4885 |
| US-11393989-B2 | Organic electroluminescent devices and metal complex compounds | EPCAM, TPR, L1CAM | BRS3 4421/4885GAA 2170/4885PTGS1 4257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.